Pharmafile Logo
Pharmafocus logo
Advanced Search

Woodley Equipment Company Exhibiting at Outsourcing in Clinical Trials West Coast 2017

February 15, 2017
Lab Equipment supplier, Medical Equipment Supplier, medical equipment

The Clinical Trials Team at Woodley Equipment Company is exhibiting at Outsourcing in Clinical Trials West Coast 2017 which is taking place …

News
Press release
shutterstock_159488225

New cancer drug could give hope to non-responsive patients

February 15, 2017
Research and Development Cancer

A new dual action drug developed as part of a collaboration between biopharmaceutical oncology firm Almac Discovery and The Royal …

News

Stada encourages bidding war, with figure of €3.5 billion mooted

February 15, 2017
Research and Development, Sales and Marketing Advent International, Cinven, Stada

Stada, the German generic drugmaker, has received two offers for takeover, with one estimated to be €3.5 billion, thought to …

News
shutterstock_146497481

US panel endorses human embryo gene editing, with caveats

February 15, 2017
Research and Development crispr, gene editing

Gene editing in human embryos has been given the go-ahead by a panel of experts from the US National Academy …

News
merck_entrance

MSD’s Alzheimer’s drug failure undermines potential treatment pathway

February 15, 2017
Research and Development Alzheimer's, MSD, Merck

MSD, known as Merck in North America, has announced that it has been forced to cancel a Phase 2/3 trial …

News
device_magnetic

Magnetic implant could revolutionise drug delivery

February 15, 2017
Research and Development University of British Colombia, University of British Colombia - Device next to Canadian one dollar coin., magnetic implant

Researchers from the University of British Columbia have invented a new method of drug delivery that relies on magnets to …

News
614px-flexed_plastic_display

Plastic electronics to bring “mind-blowing” developments for pharma

February 14, 2017
Manufacturing and Production, Research and Development plastic electronics

Plastic electronics could be the next big thing for pharma production and treatment , according to a new report on …

News
down_arrow

Hepatitis C market set for slump as cure rates rise

February 14, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Gilead, hepatitis C

Objectively, it is the pharmaceutical industries intention to find cures for diseases and to aid patients to live a full …

News
gsk_boronia_australia

GSK unveils strong showing for twin-drug HIV treatment

February 14, 2017
Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, HIV, Tivicay

GlaxoSmithKline has announced strong Phase 3 findings for its own Tivicay (dolutegravir) as part of a twin-drug regimen with J&J’s …

News
marathon_logo

Marathon’s major misstep shows that drug pricing debate is here to stay

February 14, 2017
Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Emflaza, marathon

Marathon Pharmaceuticals’ approval, last week, by the FDA for its treatment for Duchenne muscular dystrophy would usually have been cause …

News
allergan

Allergan set to bolster ‘medical aesthetics’ unit with $2.5 billion Zeltiq deal

February 13, 2017
Manufacturing and Production, Sales and Marketing Allergan, FDA, Zeltiq

Allergan, the owner of Botox, has expanded its stake in the ‘medical aesthetics’ business by acquiring Zeltiq Aesthetics. Zeltiq has …

News

Pfizer and Flynn: How are ‘excessive’ prices for generic drugs possible and should competition authorities do more about exploitative pricing?

February 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, Pfizer, flynn

As last year came to a close, the headlines were rocked by the news that pharma giant Pfizer had been …

Feature

NICE turns down AZ’s chronic obstructive pulmonary disease drug

February 13, 2017
Sales and Marketing AstraZeneca, Daxas, NICE, chronic obstructive pulmonary disease

AstraZeneca’s Daxas (roflumilast) has been knocked back in draft guidance by the National Institute for Health and Care Excellence (NICE), …

News
headquarters_2_web

Lilly €200m expansion of Cork site under review

February 13, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Ireland, cork

Eli Lilly’s planned €200m investment to its manufacturing plant in Kindsdale, County Cork, is now under-review. The expansion would bring …

News
ipsen_small

Ipsen to acquire Sanofi assets in $88 million deal

February 13, 2017
Sales and Marketing Boehringer Ingelheim, Prontalgine, Sanofi, ipsen

Ipsen has announced that it is set to enter into a definitive agreement to acquire five consumer healthcare products from …

News
iphone

First-ever approved fertility app more effective than the pill, experts say

February 13, 2017
Research and Development, Sales and Marketing contraception

Fertility app Natural Cycles has become the first-ever smartphone application and software solution to be approved by experts as a …

News
seattle_genetics

Seattle Genetics’ prospective $2 billion licensing deal not without controversy

February 13, 2017
Sales and Marketing Immunomedics, Seattle Genetics, enVio

Immunomedics announced on 10 February that it had entered a licensing agreement with Seattle Genetics for its leading experimental cancer …

News
erez_vigodman

Teva’s Vigodman becomes third CEO to leave in 5 years

February 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Teva has maintained its habit of changing CEOs rather frequently, as Erez Vigodman has left by “mutual agreement”. He becomes …

Appointment
thomas-cueni

Thomas Cueni named as new IFPMA Director General

February 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IFPMA

Thomas Cueni has become the new Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and will …

Appointment
intelligent_fingerprinting

Intelligent Fingerprinting secures £3 million funding for portable drug screening

February 10, 2017
Medical Communications, Research and Development Intelligent Fingerprinting, drug testing, nanotechnology

Intelligent Fingerprinting has received a funding boost to market its fingerprint-based drug screening system further. It is the world’s first …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026